NCT05088889 2023-11-28
Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer
Sheba Medical Center
Phase 1 Unknown
Clinical Trials
12 trialsNCT05147168 2023-11-14
Quality of Life of Pancreatic Cancer Patients:Psychometric Validation of Chinese Version in Taiwan
Taipei Veterans General Hospital, Taiwan
Unknown
NCT05270564 2022-03-08
Drain 1
Linkoeping University
Phase NA Unknown
NCT04352023 2020-04-17
Analgesic Efficacy After Pancreatobiliary Surgery: Intravenous Versus Patient-controlled Epidural
National Cancer Center, Korea
Phase 2 Unknown
NCT03838029 2019-11-20
BC-PC
Assaf-Harofeh Medical Center
Phase 2 Unknown
NCT04158414 2019-11-08
Applying PET/MR in Oncology - a Prospective Project
Tel-Aviv Sourasky Medical Center
Phase NA Unknown
NCT02479984 2017-09-14
Diagnostic Laparoscopy in the Preoperative Staging of Pancreatobiliary Cancer
National Cancer Center, Korea
Phase NA Unknown
NCT03178812 2017-06-07
Role of the Cystic Fluid Interleukins and Tumor Necrosis Factor (TNF) Levels in Characterizing Pancreatic Cysts Detected by Endoscopic Ultrasound (EUS)
Hillel Yaffe Medical Center
Phase NA Unknown
NCT03166436 2017-05-30
RFA for Malignant Biliary Obstruction
Institute for Clinical and Experimental Medicine
Phase NA Unknown
NCT01608841 2015-02-18
The Role of EGFR Mutations in Pancreatic Cancer Patients Receiving Gemcitabine With or Without Erlotinib
Taipei Veterans General Hospital, Taiwan
Phase 2 Unknown
NCT00658840 2012-04-03
Concurrent Chemo-radiotherapy With Capecitabine for Unresectable Locally Advanced Pancreatic Carcinoma
National Cancer Center, Korea
Phase 2 Unknown
NCT00486460 2007-06-14
Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer
Tel-Aviv Sourasky Medical Center
Phase 3 Unknown